1
|
Hovdenes J, Laake JH, Aaberge L, Haugaa H
and Bugge JF: Therapeutic hypothermia after out-of-hospital cardiac
arrest: experiences with patients treated with percutaneous
coronary intervention and cardiogenic shock. Acta Anaesthesiol
Scand. 51:137–142. 2007. View Article : Google Scholar
|
2
|
Osadchii OE: Mechanisms of
hypokalemia-induced ventricular arrhythmogenicity. Fundam Clin
Pharmacol. 24:547–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bae JH, Park CW, Cho JH, Kim YS, Lee HY
and Won MH: The potential mechanism of the detrimental effect of
defibrillation prior to cardiopulmonary resuscitation in prolonged
cardiac arrest model. Lab Anim Res. 30:79–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Langley P, MacGowan GA and Murray A:
Spatial and temporal organization of the dominant frequencies in
the fibrillating heart: body surface potential mapping in a rare
case of sustained human ventricular fibrillation. Europace.
11:324–327. 2009. View Article : Google Scholar
|
5
|
Tribulová N, Knezl V, Okruhlicová L and
Slezák J: Myocardial gap junctions: targets for novel approaches in
the prevention of life-threatening cardiac arrhythmias. Physiol
Res. 57(Suppl 2): S1–S13. 2008.
|
6
|
Chaldoupi SM, Loh P, Hauer RN, de Bakker
JM and van Rijen HV: The role of connexin40 in atrial fibrillation.
Cardiovasc Res. 84:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Axelsen LN, Haugan K, Stahlhut M, et al:
Increasing gap junctional coupling: a tool for dissecting the role
of gap junctions. J Membr Biol. 216:23–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Fialová M, Dlugosová K, Okruhlicová L,
Kristek F, Manoach M and Tribulová N: Adaptation of the heart to
hypertension is associated with maladaptive gap junction
connexin-43 remodeling. Physiol Res. 57:7–11. 2008.
|
9
|
Lee PJ and Pogwizd SM: Micropatterns of
propagation. Adv Cardiol. 42:86–106. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
van Rijen HV, de Bakker JM and van Veen
TA: Hypoxia, electrical uncoupling, and conduction slowing: Role of
conduction reserve. Cardiovasc Res. 66:9–11. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Moffitt JA, Henry MK, Welliver KC, Jepson
AJ and Garnett ER: Hindlimb unloading results in increased
predisposition to cardiac arrhythmias and alters left ventricular
connexin 43 expression. Am J Physiol Regul Integr Comp Physiol.
304:R362–R373. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yi SL, Zhong JQ, Zhang J, Su GY, Li JS,
Liu HZ and Zhang Y: ZP123 reduces energy required for
defibrillation by preventing connexin43 remodeling during prolonged
ventricular fibrillation in swine. Tex Heart Inst J. 39:784–791.
2012.
|
13
|
Li JS, Zhong JQ, Zeng QX, Liu HZ, Su GY
and Zhang Y: Effect of ZP123, a gap junction modifier, on prolonged
ventricular fibrillation in swine. Cardiology. 118:147–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu HZ, Zhong JQ, Li JS, Su GY, Wang J and
Zhang Y: Changes in myocardial connexin 43 during ventricular
fibrillation. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 22:595–598.
2010.In Chinese. PubMed/NCBI
|
15
|
Salameh A and Dhein S: Adrenergic control
of cardiac gap junction function and expression. Naunyn
Schmiedebergs Arch Pharmacol. 383:331–346. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sattur S and Kern KB: Increasing CPR
duration prior to first defibrillation does not improve return of
spontaneous circulation or survival in a swine model of prolonged
ventricular fibrillation. Resuscitation. 80:382author reply
382–383. 2009. View Article : Google Scholar
|
17
|
Echt DS, Liebson PR, Mitchell LB, et al:
Mortality and morbidity in patients receiving encainide,
flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N
Engl J Med. 324:781–788. 1991. View Article : Google Scholar : PubMed/NCBI
|
18
|
Waldo AL, Camm AJ, deRuyter H, et al:
Effect of d-sotalol on mortality in patients with left ventricular
dysfunction after recent and remote myocardial infarction. The
SWORD Investigators. Survival With Oral d-Sotalol. Lancet.
348:7–12. 1996. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dhein S, Larsen BD, Petersen JS and Mohr
FW: Effects of the new antiarrhythmic peptide ZP123 on epicardial
activation and repolarization pattern. Cell Commun Adhes.
10:371–378. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Xing D, Kjølbye AL, Petersen JS and
Martins JB: Pharmacological stimulation of cardiac gap junction
coupling does not affect ischemia-induced focal ventricular
tachycardia or triggered activity in dogs. Am J Physiol Heart Circ
Physiol. 288:H511–H516. 2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Xing D, Kjølbye AL, Nielsen MS, et al:
ZP123 increases gap junctional conductance and prevents reentrant
ventricular tachycardia during myocardial ischemia in open chest
dogs. J Cardiovasc Electrophysiol. 14:510–520. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Haugan K, Marcussen N, Kjølbye AL, Nielsen
MS, Hennan JK and Petersen JS: Treatment with the gap junction
modifier rotigaptide (ZP123) reduces infarct size in rats with
chronic myocardial infarction. J Cardiovasc Pharmacol. 47:236–242.
2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hennan JK, Swillo RE, Morgan GA, et al:
Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias
and reduces infarct size during myocardial ischemia/reperfusion
injury in open-chest dogs. J Pharmacol Exp Ther. 317:236–243. 2006.
View Article : Google Scholar
|
24
|
Zhong JQ, Laurent G, So PP, Hu X, Hennan
JK and Dorian P: Effects of rotigaptide, a gap junction modifier,
on defibrillation energy and resuscitation from cardiac arrest in
rabbits. J Cardiovasc Pharmacol Ther. 12:69–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Eloff BC, Gilat E, Wan X and Rosenbaum DS:
Pharmacological modulation of cardiac gap junctions to enhance
cardiac conduction: evidence supporting a novel target for
antiarrhythmic therapy. Circulation. 108:3157–3163. 2003.
View Article : Google Scholar : PubMed/NCBI
|